Minoo Ahmadinejad/LinkedIn
Dec 31, 2025, 03:21
Minoo Ahmadinejad: 5th IRSTH Annual Congress on Thrombosis and Hemostasis | December 31, 2025 – January 2, 2026
Minoo Ahmadinejad, Laboratory Director at Iranian Blood Transfusion Organization, shared on LinkedIn:
“Annual Congress on Thrombosis and Hemostasis
31 December 2025– 2 January 2026
As President of our IRanian Society of Thrombosis and Hemostasis ,IRSTH, I’m proud to share that this congress is one of Iran’s most significant scientific gatherings in the field of thrombosis and hemostasis.
We welcome scientists, clinicians, and specialists from across the country to join us, exchange knowledge, and shape the future of patient care together.
Don’t miss this opportunity to connect, collaborate, and contribute!”
Explore more posts for deeper insights into hemostasis with Hemostasis Today.
-
Apr 6, 2026, 16:39Dhinesh Selvaraju: FDA Approves Narsoplimab (Yartemlea) as 1st Treatment for TA-TMA in Adults and Children
-
Apr 6, 2026, 16:38Linda Vorberg: A Detailed Analysis on The Usefulness of CT for DL-Based Stroke Lesion Segmentation
-
Apr 6, 2026, 16:37Colleen Hearn: Telestroke Helps Resource-Limited Facilities Gain Access to Unavailable Expertise
-
Apr 6, 2026, 16:37Nicolas Hubacz: AI Maps Neuroplasticity in Stroke Recovery – How the Brain Adapts After Injury
-
Apr 6, 2026, 16:36Cristina de Diego Alonso: Movement Is Not Just an Exercise, It Is The Rhythm of Daily Life
-
Apr 6, 2026, 16:35Charles Okyere Boadu: What Is The Most Likely Cause of Persistent Thrombocytopenia Despite Transfusion?
-
Apr 6, 2026, 16:34Tumor Mutations and VTE Risk – New Insights from a 12,500-Patient Cancer Study – JTH
-
Apr 6, 2026, 16:31Wolfgang Miesbach: New Real-World Data Reveal Ongoing Burden in Moderate-to-Severe Haemophilia A
-
Apr 6, 2026, 16:26Heghine Khachatryan։ Targeting High Risk Antiphospholipid Syndrome in Pregnancy with Hydroxychloroquine